Detecting (or screening for) Covid-19 even before symptoms fully manifest, could enable patients to receive timely and life-saving treatment. Prior work has demonstrated that heart rate and step data from low-en
Consumer wearable devices that continuously measure vital signs have been used to monitor the onset of infectious disease. Here, we show that data from consumer smartwatches can be used for the pre-symptomatic detection of coronavirus disease 2019 (COVID
During the first wave of the COVID-19 pandemic, routine SARS-CoV-2 testing in long-term care facilities in the Province of Salzburg and centralized hospitalization in the COVID-19 unit of the Paracelsus Medical University Salzburg (Austria) irrespective of symptoms was implemented. Baseline ...
Thus, our data show that gastrointestinal symptoms pre-admission were associated with increased severity of COVID-19. These results are consistent with other recent studies,4,7,8 but mostly these had not considered other potential confounding factors. There have been some contradictory reports.9,10...
Thus, they were not asymptomatic, but pre-symptomatic, and they eventually experienced the onset of symptoms, which meant that they were reclassified into one of the other case defini- tions (i.e., mild, moderate, severe, critical) [5]. As of April 7, 2020, a total of 81 802 COVID...
We estimated that 32/80 (40%) of transmission events were likely to have occurred prior to symptoms onset in primary cases. Secondary cases in clusters had less severe illness on average than cluster primary cases. Conclusions The majority of transmissions are occurring around illness onset in an...
The outbreak of COVID-19 was firstly reported in December 2019 in Wuhan City, Hubei Province, People's Republic of China, and the infected patients were diagnosed with symptoms of intense respiratory disorder, headache, fatigue, throat pain, mild fever and others [4,5]. Specifically, a few ...
increased risk, compared to other variants, for COVID-19 due to emergent SARS-CoV-2 viral variants not neutralized by PEMGARDA. If signs and symptoms of COVID-19 occur, advise individuals to test for COVID-19 and seek medical attention, including starting treatment for C...
Sex differences in incidence of respiratory symptoms and management by general practitioners. Fam Pract. 2020;37(5):631-636. doi:10.1093/fampra/cmaa040 PubMedGoogle ScholarCrossref 37. Bwire GM. Coronavirus: why men are more vulnerable to COVID-19 than women? SN Compr ...
The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS〤oV2) is the causative agent of coronavirus disease 2019 (COVID). The presenting symptoms of this virus are variable, and there is an increasing body of literature on risk factors for mortality. The aim of this study ...